How has the dna and gene cloning services market evolved, and where is it heading next?
The DNA and gene cloning services market size has grown rapidly in recent years. It will grow from $2.69 billion in 2024 to $3.07 billion in 2025 at a compound annual growth rate (CAGR) of 14.2%. The growth in the historic period can be attributed to increase in demand for personalized medicine, rise in investment in biopharmaceutical research, growth in prevalence of genetic disorders, expanding applications in agriculture and biotechnology, and supportive government funding for genomic studies.
The DNA and gene cloning services market size is expected to see rapid growth in the next few years. It will grow to $5.16 billion in 2029 at a compound annual growth rate (CAGR) of 13.9%. The growth in the forecast period can be attributed to increasing demand for personalized medicine, rising applications in gene therapy, growing investments in biopharmaceutical R&D, expanding use of synthetic biology, supportive government regulations and funding for biotechnology, and the growing prevalence of genetic disorders. Major trends in the forecast period include enhanced CRISPR-Cas9 precision, cost-effective next-generation sequencing, automated cloning platforms, high-throughput screening methods, synthetic biology innovations, AI-driven gene analysis, and improved vector design for therapeutic applications.
Get Your Free Sample of The Global DNA And Gene Cloning Services Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21173&type=smp
What are the key drivers behind the rapid expansion of the dna and gene cloning services market?
The rise in gene therapy is expected to drive the growth of the DNA and gene cloning services market going forward. Gene therapy is a treatment method that alters a person’s genes to cure or prevent diseases. It can involve replacing defective genes, deactivating harmful ones, or adding new genes to combat illnesses. The rise in gene therapy is driven by its potential to treat previously incurable genetic disorders, advancements in biotechnology, and growing awareness among healthcare professionals and patients. DNA and gene cloning services are essential in gene therapy for developing targeted genetic modifications to treat genetic disorders. For instance, in April 2024, according to the American Society of Gene & Cell Therapy, a US-based non-profit medical and scientific organization, in the fourth quarter, the number of phase III gene therapy clinical trials rose by 10%, marking the first quarterly increase since the third quarter of 2022. Therefore, the rise in gene therapy is driving the DNA and gene cloning services market.
What is the segmentation for the dna and gene cloning services market?
The DNA and gene cloning services market covered in this report is segmented –
1) By Type Of Gene: Standard Gene, Complex Gene, Other Types Of Genes
2) By Service Type: Gene Synthesis, Custom Cloning, Subcloning, Other Service Types
3) By Application: DNA Sequencing, Mutagenesis, Genotyping, Other Applications
4) By End-User Industry: Academic And Research And Development (RAndD), Pharmaceutical And Biotechnology Companies, Other End User Industries
Subsegments:
1) By Standard Gene: Cloning Of Protein-coding Genes, Non-coding Genes
2) By Complex Gene: Multi-exon Genes, Genes With Alternative Splicing, Large Or Multi-structural Genes
3) By Other Types Of Genes: Synthetic Genes, Viral Genes, Genomic DNA Cloning
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/dna-and-gene-cloning-services-global-market-report
Who are the most influential companies in the dna and gene cloning services market?
Major companies operating in the DNA and gene cloning services market are Merck KGaA, Thermo Fisher Scientific Inc., Danaher Corporation, Eurofins Scientific, Agilent Technologies Inc., Lonza Group, Sartorius AG, Charles River Laboratories, Bio-Rad Laboratories Inc., Bio-Techne, Curia Global Inc., Integrated DNA Technologies Inc., GenScript Biotech Corporation, Takara Bio Inc., Syngene International Limited, Twist Bioscience, New England Biolabs Inc., Origene Technologies Inc., MedGenome, Sino Biological, Genewiz Inc., Creative Biogene, Addgene.
What are the most influential trends expected to drive the dna and gene cloning services market forward?
Major companies operating in the DNA and gene cloning services market are focusing on technological advancements such as artificial intelligence (AI)-generated gene editors to enhance accuracy, reduce development time, and streamline processes for customized genetic modifications and therapeutic applications. An AI-generated gene editor refers to a gene-editing tool or system designed, optimized, or enhanced using artificial intelligence (AI). For instance, in April 2024, Profluent, a US-based biotechnology research company, launched OpenCRISPR-1, an AI-designed gene editor. This showcases precision genome editing with customizable CRISPR-like proteins created through large language models, significantly expanding CRISPR capabilities and revolutionizing genetic science.
What are the major regional insights for the dna and gene cloning services market, and which region holds the top position?
North America was the largest region in the DNA and gene cloning services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the DNA and gene cloning services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The DNA And Gene Cloning Services Market Report 2025 Offer?
The dna and gene cloning services market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Deoxyribonucleic acid (DNA) and gene cloning services refer to laboratory techniques used to create copies of specific DNA sequences or genes. These services involve inserting a gene of interest into a plasmid vector, which is then introduced into a host organism (such as bacteria) to replicate and produce multiple copies of the gene. This process is essential for various applications in research, medicine, and biotechnology.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21173
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
